Slovenia's Lek breaks ground for 400 mln euro biosimilars plant | Companies

Slovenian pharmaceutical company Lek started the construction of a 400 million euro ($432 million) biosimilars production plant in Lendava, the government said.

Related Keywords

Lendava ,Lendava Lendva ,Slovenia ,Slovenian , ,Slovenian Pharmaceutical Company Lek Started The Construction Ofa 400 Million Euro 432 Biosimilars Production Plant In Lendava ,He Government Said ,